Alben, Matthew G. http://orcid.org/0000-0001-7398-4088
Gordon, Dan
Gambhir, Neil http://orcid.org/0000-0002-1571-0780
Kim, Matthew T. http://orcid.org/0000-0003-2601-2969
Romeo, Paul V. http://orcid.org/0000-0002-2862-7855
Rokito, Andrew S. http://orcid.org/0000-0003-2614-8639
Zuckerman, Joseph D. http://orcid.org/0000-0003-3072-9970
Virk, Mandeep S. http://orcid.org/0000-0001-6294-2771
Funding for this research was provided by:
NYU Langone Medical Center
Article History
Received: 30 July 2022
Accepted: 7 December 2022
First Online: 9 January 2023
Declaration
:
: This study was approved by the NYU Langone Health Institutional Review Board (s20-00287).
: Joseph D. Zuckerman, MD: Apos Therapy, Inc. (Stock); Hip Innovation Technology (Stock); Musculoskeletal Transplant Foundation (Board Member); SLACK Inc. (Publishing Royalties); Thieme Inc. (Publishing Royalties); Wolters Kluwer Health (Publishing Royalties); Exactech (Design Surgeon, Royalties). Mandeep S. Virk, MD: Exactech (Paid Consultant); Acumed Inc. (Paid Consultant). The other authors of this paper certify that they have NO affiliations with or involvement in any organization or entity with any financial or non-financial interests pertinent to the subject matter discussed in this manuscript.